|
WO2018044020A1
|
|
Method for preparing eperisone sustained release microsphere, and composite preparation of eperisone sustained release microsphere and aceclofenac
|
|
KR20190011043A
|
|
Process for preparing dipyridamole sustained release pellet including fumaric acid as core ingredient
|
|
KR20190011045A
|
|
The complex formulation of dipyridamole plus fumaric acid sustained release pellet and aspirin
|
|
KR20170026431A
|
|
Pharmaceutical composition for treating renal disease including dipyridamole as active ingredient
|
|
KR101760278B1
|
|
Process for preparing sustained release microsphere including eperisone as active ingredient
|
|
KR101799321B1
|
|
The complex formulation of eperisone sustained release microsphere and aceclofenac
|
|
KR20170022562A
|
|
Screening method of the effective material for treating and preventing complex metabolic disease accompanying diabetes and obesity
|
|
KR20170005539A
|
|
Pharmaceutical composition for treating renal disease including dipyridamole as active ingredient
|
|
KR20160136999A
|
|
The complex formulation of dipyridamole sustained release pellet and aspirin
|
|
KR20160136998A
|
|
Process for preparing core-shell sustained release pellet including dipyridamole as active ingredient
|
|
KR101621739B1
|
|
Bicyclic lactone compound for treating gastro-intestinal disease
|
|
KR101621740B1
|
|
Bicyclic lactone compound for treating gastro-intestinal disease
|
|
KR101621742B1
|
|
Bicyclic lactone compound for treating gastro-intestinal disease
|
|
KR101478543B1
|
|
Pharmaceutical composition for treating chronic myelogenous leukemia containing yellow poplar bark extract
|
|
KR20150064384A
|
|
Pharmaceutical preparation for treating chronic myelogenous leukemia containing yellow-poplar bark extract as active ingredient
|
|
KR101431567B1
|
|
Pharmaceutical composition for treating chronic myelogenous leukemia containing yellow poplar extract
|
|
KR20140127985A
|
|
Process for extracting and separating the components for treating chronic myelogenous leukemia from yellow poplar cortex
|
|
KR20140118410A
|
|
Eperisone pharmaceutical composition enhancing storage and pH stability
|
|
KR20140118412A
|
|
Slow release pharmaceutical composition having Eperisone as active ingredient
|
|
KR101378430B1
|
|
Pharmaceutical composition for treating gastric disease having sesquiterpene lactone skeleton
|
